Market Overview

Earnings Scheduled For March 19, 2014

Related FDX
UPDATE: Morgan Stanley Reiterates On FedEx Corporation As Stock Enters FY15 With Momentum
#PreMarket Primer: Thursday, September 18: Scotland Heads To The Polls
Buyback Mania Inflates 2Q Earnings Growth (Fox Business)
Related ESLT
UPDATE: Elbit Posts Upbeat Q2 Profit
4 Defense Stocks To Watch Amid Israeli - Palestinian Unrest

FedEx (NYSE: FDX) is projected to report its Q3 earnings at $1.46 per share on revenue of $11.43 billion.

Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $1.41 per share on revenue of $839.97 million.

General Mills (NYSE: GIS) is projected to report its Q3 earnings at $0.64 per share on revenue of $4.41 billion.

Jabil Circuit (NYSE: JBL) is expected to post its Q2 earnings at $0.11 per share on revenue of $3.61 billion.

KB Home (NYSE: KBH) is estimated to report its Q1 earnings at $0.08 per share on revenue of $435.30 million.

Guess' (NYSE: GES) is expected to post its Q4 earnings at $0.79 per share on revenue of $762.94 million.

Vera Bradley (NASDAQ: VRA) is projected to report its Q4 earnings at $0.46 per share on revenue of $146.86 million.

Bacterin International Holdings (NYSE: BONE) is estimated to post a Q4 loss at $0.07 per share on revenue of $8.00 million.

CLARCOR (NYSE: CLC) is expected to post its Q1 earnings at $0.41 per share on revenue of $317.45 million.

Cintas (NASDAQ: CTAS) is projected to post its Q3 earnings at $0.69 per share on revenue of $1.13 billion.

Franco-Nevada (NYSE: FNV) is estimated to post its Q4 earnings at $0.22 per share on revenue of $96.32 million.

Tilly's (NYSE: TLYS) is expected to post its Q4 earnings at $0.18 per share on revenue of $139.75 million.

Herman Miller (NASDAQ: MLHR) is projected to post its Q3 earnings at $0.34 per share on revenue of $457.60 million.

Actuant (NYSE: ATU) is expected to report its Q2 earnings at $0.32 per share on revenue of $333.74 million.

The ExOne Company (NASDAQ: XONE) is estimated to post its Q4 earnings at $0.01 per share on revenue of $12.13 million.

Sinovac Biotech (NASDAQ: SVA) is projected to post a Q4 loss at $0.01 per share on revenue of $20.35 million.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

 

Related Articles (ATU + BONE)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional